21 November 2017
News and Views
Links and Services
April's issue of the Alimentary Pharmacology & Therapeutics identifies predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
The increasing incidence of Clostridium difficile infection among patients with inflamma
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors